In this study, by using in vivo and ex vivo experimental models of thyroid cancer we show the possibility to obtain a reliable thyroid cancer imaging in vivo by targeting the galectin-3 lectin molecule. The gene discussed is LGALS3; the disease is thyroid gland carcinoma.